Posted On: 03/17/2014 11:17:16 AM
Post# of 63824
$CUR gap breakout Pr $4.00
10-K 3/14/14
shares outstanding of Registrant’s common stock,
$0.01 par value at February 28, 2014 was 86,218,421
Final Results Of Neuralstem Phase I Stem Cell Trial
In Amyotrophic Lateral Sclerosis Published In Annals of Neurology
3/17/2014 9:15:00 AM - PR Newswire
Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS
3/11/2014 10:30:00 AM - Seeking Alpha
Osiris Therapeutics: Poised For Another Breakout
3/11/2014 2:07:00 AM - Seeking Alpha
Neuralstem Announces 2013 Financial Results
3/10/2014 9:00:00 AM - PR Newswire
10-K 3/14/14
shares outstanding of Registrant’s common stock,
$0.01 par value at February 28, 2014 was 86,218,421
3/17/2014 9:15:00 AM - PR Newswire
3/11/2014 10:30:00 AM - Seeking Alpha
3/11/2014 2:07:00 AM - Seeking Alpha
3/10/2014 9:00:00 AM - PR Newswire
(0)
(0)
